Suboptimal mixed vaccine and chemotherapy in finite duration cancer treatment: state-dependent Riccati equation control

Abstract The aim of this paper is to propose an optimal finite duration treatment method for avoiding tumor growth. For this purpose, a mathematical model in the form of ordinary differential equations is modified with combination vaccine therapy and chemotherapy treatments. Numerical simulations, using human parameters, show that there are two equilibrium points. The tumor-free equilibrium point is unstable while the high-tumor equilibrium point is stable. Hence, the dynamics of the cancer model must be changed to have finite duration treatment. Therefore, the vaccine therapy is used to change the parameters of the system and the chemotherapy is applied for pushing the system to the domain of attraction of the healthy state. It is shown that any treatment method without changing the dynamics of the system around the tumor-free equilibrium point is not an appropriate treatment method. For optimal chemotherapy, the State-Dependent Riccati Equation based optimal control is used to the nonlinear model. Different weighting matrices are used to show the flexibility of this method in design. Simulation results show that the performance of the treatment would be better if the matrix was state dependent. In this paper, the input weighting matrix depends on the tumor cell population. If the input matrix becomes less in the beginning of the treatment causes more tumor cells eradication. Also, the present study states that a proper treatment method should not only reduce the population of tumor cells, but also change the dynamics of the cancer.

[1]  G. W. Swan Role of optimal control theory in cancer chemotherapy. , 1990, Mathematical biosciences.

[2]  A. Świerniak,et al.  Mathematical modeling as a tool for planning anticancer therapy. , 2009, European journal of pharmacology.

[3]  Frank Nani,et al.  A chemotherapy model for the treatment of cancer with metastasis , 2002 .

[4]  Ami Radunskaya,et al.  The dynamics of an optimally controlled tumor model: A case study , 2003 .

[5]  H. T. Banks,et al.  Nonlinear feedback controllers and compensators: a state-dependent Riccati equation approach , 2007, Comput. Optim. Appl..

[6]  John M. Harrold,et al.  MODEL-BASED DESIGN OF CANCER CHEMOTHERAPY TREATMENT SCHEDULES , 2005 .

[7]  D. Mahmoud-Ghoneim,et al.  Neural network assessment of herbal protection against chemotherapeutic-induced reproductive toxicity , 2012, Theoretical Biology and Medical Modelling.

[8]  A. Ghaffari,et al.  Cancer dynamics for identical twin brothers , 2012, Theoretical Biology and Medical Modelling.

[9]  J. Cloutier,et al.  Control designs for the nonlinear benchmark problem via the state-dependent Riccati equation method , 1998 .

[10]  Suzanne Lenhart,et al.  Optimal control of treatment in a mathematical model of chronic myelogenous leukemia. , 2007, Mathematical biosciences.

[11]  John Carl Panetta,et al.  Molecular biology of breast cancer metastasis: The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer , 2000, Breast Cancer Research.

[12]  T. Vincent,et al.  Optimal control analysis in the chemotherapy of IgG multiple myeloma. , 1977, Bulletin of mathematical biology.

[13]  E. Coddington,et al.  Theory of Ordinary Differential Equations , 1955 .

[14]  Fatih Safa Erenay,et al.  A survey of optimization models on cancer chemotherapy treatment planning , 2014, Ann. Oper. Res..

[15]  Chronic Disease Division Cancer facts and figures , 2010 .

[16]  Stephen P. Banks,et al.  Optimal control of drug therapy in cancer treatment , 2009 .

[17]  Gholamreza Vossoughi,et al.  Optimal robust control of drug delivery in cancer chemotherapy: A comparison between three control approaches , 2013, Comput. Methods Programs Biomed..

[18]  Robert S. Parker,et al.  Clinically relevant cancer chemotherapy dose scheduling via mixed-integer optimization , 2009, Comput. Chem. Eng..

[19]  D L S McElwain,et al.  A history of the study of solid tumour growth: The contribution of mathematical modelling , 2004, Bulletin of mathematical biology.

[20]  Jon C. Aster,et al.  Robbins BASIC PATHOLOGY , 2002, Robbins Basic Pathology.

[21]  C. Klein,et al.  Systemic Cancer Progression and Tumor Dormancy: Mathematical Models Meet Single Cell Genomics , 2006, Cell cycle.

[22]  A. Murugan,et al.  Chemotherapy for tumors: an analysis of the dynamics and a study of quadratic and linear optimal controls. , 2007, Mathematical biosciences.

[23]  Harvey Thomas Banks,et al.  A state‐dependent Riccati equation‐based estimator approach for HIV feedback control , 2006 .

[24]  Ami Radunskaya,et al.  A mathematical tumor model with immune resistance and drug therapy: an optimal control approach , 2001 .

[25]  Y. Batmani,et al.  Optimal chemotherapy in cancer treatment: state dependent Riccati equation control and extended Kalman filter , 2013 .

[26]  A. Radunskaya,et al.  Mixed Immunotherapy and Chemotherapy of Tumors: Modeling, Applications and Biological Interpretations , 2022 .

[27]  Metin U. Salamci,et al.  SDRE optimal control of drug administration in cancer treatment , 2010 .